Previous studies report genetic polymorphisms in NUDT15 to affect the metabolism of thiopurine drugs (azathioprine, mercaptopurine, and thioguanine) that are associated with leukemia treatment [14]. This evidence concerns the gene NUDT15 and leukemia.